Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 7 USDMF, 20 CEP/COS, 2 JDMF, 1 EU WC, 8 KDMF, 9 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

536 FDF Dossiers, 187 FDA Orange Book, 123 Europe, 49 Canada, 134 South Africa, 43 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 325MG;50MG;40MG;30MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 300MG;60MG, SYRUP;ORAL - 10MG/5ML;6.25MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 7 SPI Pharma, 12 DKSH, 2 Pharm-RX Chemical, 7 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Kirsch Pharma, 4 ACG Worldwide, 14 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 31 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 1 Clariant, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 15 Kerry, 3 Keval Exports, 3 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 34 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 42 Thickeners and Stabilizers, 38 Disintegrants & Superdisintegrants, 37 Direct Compression, 33 Granulation, 28 Solubilizers, 26 Parenteral, 23 Topical, 22 Taste Masking, 20 Lubricants & Glidants, 19 Film Formers & Plasticizers, 15 Controlled & Modified Release, 14 Coating Systems & Additives, 13 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 8 Empty Capsules, 6 Rheology Modifiers, 5 Surfactant & Foaming Agents, 3 API Stability Enhancers, 3 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

20 News #PharmaBuzz

20 News #PharmaBuzz

GLOBAL SALES INFORMATION

26 Regulatory FDF Prices

26 Regulatory FDF Prices

MARKET PLACE

29 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	EUROAPI	France	Nosa Chemical Co., Ltd.	20200616-209-J-616	codeine phosphate monohydrate	2020-06-16	Saneca Pharmaceuticals as	Slovakia	Nitrianska 100, 920 27 Hlohovec, Slovak Republic
29/11/2025	Veranova	U.S.A	Baeksu Pharmaceutical Co., Ltd.	20210316-209-J-603(1)	codeine phosphate monohydrate	2021-03-16	Macfarlan Smith Limited@Macfarlan Smith Limited@Tasmanian Alkaloids Pty Limited	U.S.A	Three Trees Road, Newbie, Annan Dumfriesshire, DG12 5QH, United Kingdom@10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom@160 Birralee Road, Westbury, Tasmania, 7303, Australia

PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers

7 USDMF

20 CEP/COS

2 JDMF

1 EU WC

8 KDMF

9 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

536 FDF Dossiers

187 FDA Orange Book

123 Europe

49 Canada

134 South Africa

43 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET;ORAL - 300MG;15MG

TABLET;ORAL - 300MG;30MG

TABLET;ORAL - 300MG;60MG

TABLET;ORAL - 300MG;60MG

SYRUP;ORAL - 10MG/5ML;6.25MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

7 SPI Pharma

12 DKSH

2 Pharm-RX Chemical

7 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

8 Kirsch Pharma

4 ACG Worldwide

14 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

31 BASF

1 Bioplus Life Sciences

3 CD Formulation

1 Clariant

7 DFE Pharma

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

1 Ideal Cures

4 Ingredion Pharma Solutions

15 Kerry

3 Keval Exports

3 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

4 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qualicaps

34 Roquette

7 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

1 Symrise